74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
64.19 - Other monetary intermediation
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | -1,4 | -1 | 29,7 |
EBITDA | 1,6 | -1,2 | -0,5 | 60,4 |
Short time liabilities | 0,7 | 2,1 | 2,8 | 34,7 |
Equity capital | 1,6 | 0,3 | -0,7 | -346,2 |
Operating profit (EBIT) | 1,5 | -1,3 | -0,7 | 45,2 |
Assets | 2,4 | 2,4 | 2,1 | -11,7 |
Net profit (loss) | 1,3 | -1,4 | -1 | 29,7 |
Cash | 0,2 | 0 | 0 | 648,7 |
Liabilities and provisions for liabilities | 0,7 | 2,1 | 2,8 | 31,8 |
Net income from sale | 4,8 | 1,2 | 0,1 | -88,2 |
Working assets | 0,9 | 0,3 | 0,2 | -21,8 |
Depreciation | 0,1 | 0,1 | 0,2 | 116,9 |
% | % | % | p.p. | |
Profitability of capital | 81,6 | -493,8 | 140,9 | 634,7 |
Equity capital to total assets | 69,4 | 11,5 | -32,1 | -43,6 |
Gross profit margin | 30,8 | -111,5 | -664,7 | -553,2 |
EBITDA Margin | 33,1 | -98,4 | -330,4 | -232 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 620 | 7090 | 6470 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane